Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/1999
06/03/1999WO1999011653A9 Novel rnase p
06/03/1999WO1999009199A3 Elongation factor-2 kinase (ef-2 kinase) and methods of use therefor
06/03/1999WO1999007729A3 Peptides having potassium channel opener activity
06/03/1999WO1999006565A3 Antifreeze proteins, dna and expression systems
06/03/1999WO1999006551B1 5' ESTs FOR SECRETED PROTEINS IDENTIFIED FROM BRAIN TISSUES
06/03/1999WO1999003993A3 Suppressors of cytokine signaling; related reagents
06/03/1999WO1998058957A9 Disulfide cross-linked glycoprotein hormone analogs, their preparation and use
06/03/1999WO1998054302A9 Human lysophosphatidic acid acyltransferase
06/03/1999CA2641217A1 Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor
06/03/1999CA2592380A1 Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor
06/03/1999CA2312000A1 Mammalian cytokine-like polypeptide-10
06/03/1999CA2311809A1 Method for inhibiting premature rupture of fetal membranes, ripening of uterine cervix and preterm labor
06/03/1999CA2311763A1 Method for producing human intervertebral disc cells
06/03/1999CA2311733A1 Proliferatively active product for treating proliferating cells
06/03/1999CA2311683A1 Secreted proteins and polynucleotides encoding them
06/03/1999CA2311610A1 Human irak-2, a human interleukin-1 receptor associated kinase-2
06/03/1999CA2311472A1 Desaturase genes and their use
06/03/1999CA2311237A1 Human proteins having transmembrane domains and dnas encoding these proteins
06/03/1999CA2311235A1 Method of mobilizing hematopoietic stem cells
06/03/1999CA2311164A1 Nucleic acid ligands of tissue target
06/03/1999CA2310987A1 Tnf ligand family gene
06/03/1999CA2310892A1 Chemokine alpha-5
06/03/1999CA2310852A1 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
06/03/1999CA2310805A1 Methods for treatment of hiv or other infections using a t cell or viral activator and anti-retroviral combination therapy
06/03/1999CA2310775A1 Mucosal delivery system comprising lipophilic thrombin inhibitors
06/03/1999CA2310725A1 Process for the production of protein fibres and products thereof
06/03/1999CA2310565A1 Human protein kinase and kinase inhibitors
06/03/1999CA2310540A1 Human cdc10 homolog
06/03/1999CA2310217A1 Extracellular matrix-binding proteins from staphylococcus aureus
06/03/1999CA2310214A1 Secreted proteins and polynucleotides encoding them
06/03/1999CA2309897A1 A novel egf motif protein obtained from a cdna library of fetal liver-spleen
06/03/1999CA2309855A1 Testosterone inhibitors and use for the protection of neurons
06/03/1999CA2309809A1 Histamine and serotonin binding molecules
06/03/1999CA2309782A1 Secreted proteins and polynucleotides encoding them
06/03/1999CA2309718A1 Secreted proteins and polynucleotides encoding them
06/03/1999CA2309677A1 Novel gene and protein expressed in neural and pancreatic tissues
06/03/1999CA2309624A1 Secreted proteins and polynucleotides encoding them
06/03/1999CA2309358A1 A-33 related antigens and their pharmacological uses
06/02/1999EP0919627A2 Defective Adenoviruses and corresponding transcomplementant celllines
06/02/1999EP0919626A2 Defective Adenoviruses and corresponding transcomplementant celllines
06/02/1999EP0919625A2 Defective Adenoviruses and corresponding transcomplementant celllines
06/02/1999EP0919624A2 Defective Adenoviruses and corresponding transcomplementant celllines
06/02/1999EP0919622A2 Surface expression of enzyme in gene directed prodrug therapy
06/02/1999EP0919620A2 TRAILLK-3: a member of the TNF ligand family
06/02/1999EP0919618A1 Active Hedgehog protein mutants, methods of production and application
06/02/1999EP0919567A1 Novel peptides and nootropic agent
06/02/1999EP0919566A2 Antimicrobial peptides and their use against plant pathogens
06/02/1999EP0919245A2 NK-1 receptor antagonist and a systemic antiinflammatory corticosteroid for the treatment of emesis
06/02/1999EP0919244A2 Combinations for the treatment of tumours
06/02/1999EP0919243A1 Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant
06/02/1999EP0919242A2 Method for administering acylated insulin
06/02/1999EP0919241A1 Therapeutic agent, treatment method, prophylactic agent, and prophylactic method for canine and feline immunological diseases
06/02/1999EP0918875A1 Novel internal ribosome entry site and vector containing same
06/02/1999EP0918872A1 A method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis
06/02/1999EP0918870A1 Chitinase materials and methods
06/02/1999EP0918868A2 Antimicrobial agents, diagnostic reagents, and vaccines based on unique apicomplexan parasite components
06/02/1999EP0918867A2 Substrate trapping protein tyrosine phosphatases
06/02/1999EP0918866A1 Anti-herpesviral agent
06/02/1999EP0918864A2 PROTEINS, IN PARTICULAR MEMBRANE PROTEINS, OF $i(HELICOBACTER PYLORI), THEIR PREPARATION AND USE
06/02/1999EP0918860A2 Tumor necrosis factor-related polypeptide
06/02/1999EP0918859A1 Testis-specific insulin homolog polypeptides
06/02/1999EP0918858A1 Common gamma chain blocking agents
06/02/1999EP0918857A1 Human induced tumor protein
06/02/1999EP0918856A2 Two human nsp-like proteins
06/02/1999EP0918855A1 Polycystic kidney disease gene
06/02/1999EP0918853A2 Antisense rna with a secondary structure
06/02/1999EP0918847A2 Cytokine-free culture of dendritic cells
06/02/1999EP0918797A2 HUMANIZED IMMUNOGLOBULIN REACTIVE WITH $g(a)4$g(b)7 INTEGRIN
06/02/1999EP0918796A1 Monoclonal antibody which agglutinates e. coli having the cs4-cfa/i family protein
06/02/1999EP0918795A1 Antiangiogenic drug to treat cancer, arthritis and retinopathy
06/02/1999EP0918794A2 Uses for wnt polypeptides
06/02/1999EP0918792A1 Dipeptide benzamidine as a kininogenase inhibitor
06/02/1999EP0918788A1 Brca1 compositions and methods for the diagnosis and treatment of breast cancer
06/02/1999EP0918787A1 Compositions and methods for antisense inhibition of protein translation
06/02/1999EP0918545A2 Tumour therapy
06/02/1999EP0918539A1 Vaccine for b-cell malignancies
06/02/1999EP0918538A1 Use of proteolytic enzymes for treating uveitis
06/02/1999EP0918537A1 Use of proteolytic enzymes for influencing cytokines
06/02/1999EP0918536A1 Composition comprising insulin and insulin-like growth factor-i (igf-i)
06/02/1999EP0918535A1 Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid
06/02/1999EP0918534A1 Peptidyl prodrugs and methods of making and using the same
06/02/1999EP0918533A2 Anti-chlamydial methods and materials
06/02/1999EP0918532A1 A novel method of detecting and treating cancer
06/02/1999EP0918524A1 Mixed chimerism and tolerance
06/02/1999EP0918469A1 Methods and compositions for increasing the anaerobic working capacity in tissues
06/02/1999EP0918458A1 Antimicrobial treatment for herpes simplex virus and other infectious diseases
06/02/1999EP0918455A1 Galanin
06/02/1999EP0845036B1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology
06/02/1999EP0793418A4 Germicidal detergent-iodine compositions including polyvinyl pyrrolidone and compatible nonionic surfactant complexors
06/02/1999EP0757718A4 Methods of use of uncoated gel particles
06/02/1999EP0693084A4 Chimeric cytokine receptors in lymphocytes
06/02/1999EP0691849B1 Oesteoblast growth stimulating compostion containing pdgf and vitamin d
06/02/1999EP0675729B1 ACTIVATION OF p53 PROTEIN
06/02/1999EP0667854B1 Peptidyl activated ketone inhibitors containing natural and unnatural peptide sequences
06/02/1999EP0521873B1 Anticoagulant proteins
06/02/1999DE19752700A1 1-Deoxy-D-xylulose-5-phosphate synthase protein and modulators
06/02/1999CN1218478A Cyclic adhesion inhibitors
06/02/1999CN1218412A Peptide-base immunotherapeutic agent for allergic diseases
06/02/1999CN1218410A Use of IL-12 and IFN-'alpha' for treatment of infections diseases
06/02/1999CN1218409A Stimulation of host defence mechanisms against viral challenges
1 ... 2510 2511 2512 2513 2514 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 ... 3163